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ABSTRACT 
The apparent Vrnax of neostriatal tyrosine hydroxy-
lase (TH) is decreased by subacute administration of 
methamphetamine (METH). It was previously postulated 
that this depression is mediated through GABAergic feed-
back inhibition of the nigral dopaminergic neurons via 
the striatonigral (SN) pathway. This hypothesis was 
tested by evaluating the effect of concurrent adminis-
tration of a GAB A transaminase inhibitor on the METH-
induced depression of TH. Three GABA-T inhibitors were 
studied: y-acetylenic GABA (yAG) , aminooxyacetic acid 
(AOM), and ethamolamine-O-sulfate (EOS). All three 
agents antagonize the METH effect; dose response curves 
were developed for yAG and AOAA. Control studies show-
ed that hypothermia was not an essential component of 
this ability to antagonize METH. 
The SN pathway was lesioned by three techniques 
to test the hypothesis that this tract is essential 
for the METH-induced depression of TH. The kainic acid 
lesion of the neostriatum destroys cell bodies by an 
"excitotoxic" action, thus eliminating the SN pathway. 
The second and third lesions, a wire knife lesion and 
I .... h . (t::T)···· ::l } C'·~.T +h an e eel-rot erm:1C 1; .. Lps1on~ 1.nterTuptecl t le 0J.'i pa,_ -
way in the crus cerebri just anterior to the substan-
tia nigra. None of the lesions prevented the METH-in-
duced depression of TH, which indicates that the SN 
path is not an essential component of the METH effect. 
Agents known to block the METH effect were evaluated 
in kainic acid lesioned rats. Haloperidol (3 mg/kg) 
still protected both lesioned and control striata 
while yAG (15 mg/kg) protected only the control striata. 
This dose of yAG did not antagonize the METH-induced 
TH depression in the kainic acid lesioned striatum. An-
other dissimilarity between the action of the two an-
tagonists of the METH effect was noted. METH caused 
the kainic acid lesioned rats to rotate ipsilateral to 
the lesioned side; both antagonists slowed the rota-
tional rate but haloperidol reversed the direction of 
rotation while yAG did not. 
v 
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The goal of this research has been to develop a 
better understanding of neurochemical changes observed 
in an animal model of subacute amphetamine intoxication. 
This work is divided into two parts: First, the evalu-
ation of effects of GABA transaminase inhibitors on 
changes of neostriatal tyrosine hydroxylase (TH) activ-
ity following repeated doses of methamphetamine; sec-
ondly, a test of the hypothesis that a specific stria-
tonigral pathway is the source of feedback inhibition 
which arises in the presence of methamphetamine. It is 
hoped that the results of these two studies will serve 
to enhance the understanding of homeostatic regulation 
of neuronal interaction and the mechanism of metham-
phetamine toxicity. 
The relationship between the two nuclei studied 
here is depicted in Fig. 1. A similar model was first 
1 
presented by Racagni et al. Of course the true nature 
of nigral and neostriatal circuitry is much more com-
plex and still controversial. Other neuronal types 
are also involved, including enkephalinergic striatal 
interneurons, substance P striatonigral neurons and 
possible recurrent collateralizations, as well as in-
puts and outputs of both nuclei involving other areas 
FIG. 1 The two long pathways are the dopaminergic 
nigrostriatal pathway (DA) and the GABAergic striato-
nigral pathway (G2). Neostriatal interneurons shown 
are cholinergic (ACH) and GABAergic (Gl). Excitatory 
(+) and inhibitory (-) actions are indicated. Kainic 
acid lesions are shown by solid crosses; the site of 
mechanical and electrothermic lesions is indicated by a 
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of the brain such as cerebral cortex, ventrolateral 
thalamus, dorsal and medial raphe, locus coeruleus 
etc. A much more complex circuit pattern has been pub-
2 
lished. The primary value of this model is that it 
is logically consistent with well known effects of 
pharmacological agents on the firing rate of nigral do-
paminergic cells and pharmacologically-induced changes 
in turnover of GABA, dopamine and acetylcholine in the 
neostriatum and in the substantia nigra. The major 
disadvantage of such models is that they are sometimes 
taken too seriously and therefore tend to codify major 
misconceptions about the functional relationships which 
we attempt to understand better. 
To help orient the reader, a brief schematic is 
presented to demonstrate that the model in Fig. 1 could 
function as a negative feedback system under the in-
fluence of methamphetamine. 
1) Methamphetamine releases dopamine onto the 
cholinergic interneuron eACH). 
2) The cholinergic interneuron is strongly in-
hibited, resulting in a decreased excitatory in-
put to the GABAergic interneuron (GI). 
3) The striatonigral projection, represented 
as G2, loses inhibition and becomes more active. 
4) Increased activity of G2 leads to increased 
5 
inhibition of the dopaminergic cell body in 
the nigra. 
It can be seen that the initial effect was increased 
stimulation of dopamine receptors on target cells in 
the nigra which led to decreased dopamine cell firing, 
a negative feedback. 
The sites of lesions performed in Part II are al-
so indicated in figure 1. The kainic acid lesion de-
stroys striatal interneurons ACH and GI as well as the 
efferent pathway, GZ. The mechanical and electrother-
mic lesions of the crus cerebri interrupt the striato-
nigral pathway, GZ, just rostral to the nigra. 
6 
References 
1. Racagni, G., Cheney, D.L., Zsilla, G., and Costa, 
E., The measurement of acetylcholine turnover rate 
in brain structures, Neuropharmacology, 15 (1976) 
723-736. 
2. Costa, E., Cheney, D.L., Mao, C.C. and Moroni, F., 
Action of antischizophrenic drugs on the metabolism 
of y-aminobutyric acid and acetylcholine in globus 
pal1idis, striatum and n. accumbens, Fed. Proc. 37 
(1978) 2408-2414. 
PART TWO 
BLOCKADE OF METHAMPHETAMINE-INDUCED DEPRESSION 
OF TYROSINE HYDROXYLASE BY GABA 
TRANSAMINASE INHIBITORS 
Introduction 
Repeated, toxic doses of methamphetamine cause a 
decrease in the apparent Vmax of tyrosine hydroxylase 
(TH) in the neostriatum and substantia nigra of rats 
7 
36 hours after the first dose. Since this type of 
methamphetamine exposure may represent a relevant ani-
mal model for predicting the effects of human paren-
teral abuse of amphetamine-like drugs, further under-
standing of the neurochemical basis of the methamphe-
tamine-induced decrease in TH activity might h~lp to 
explain certain aspects of their clinical toxicity. 
1 
Buening and Gibb originally proposed that the con-
tinuous presence of methamphetamine caused the stria-
tonigral pathway to impose a prolonged negative feed-
back onto the nigral dopaminergic neurons, which in 
turn led to a sustained inhibition of electrical activ-
ity in the nigrostriatal pathway. Because electrophys-
iological studies have demonstrated such an acute ef-
2 
fect of amphetamine , it was logical to extend this ob-
servation to neurochemical studies in a chronic abuse 
model. 
Prolonged preganglionic stimulation of adrenal 
medullary cells leads to an increase in adrenal TH ac-
tivity wllereas elimination of the preganglionic input 
10 
15 16 
consistently causes a small depression of TH activity ,. 
Therefore, the decrease in neostriatal TH activity ob-
served in methamphetamine-treated rats could also be 
due to a decrease in excitatory drive. Alternatively, 
an increase in inhibitory drive to nigral dopamine neu-
rons might induce an enzyme change similar to that seen 
in the decentralized adrenal medulla. 
The effect of methamphetamine on neostriatal TH 
1 
activity is blocked by neuroleptics and by a-methyl-p-
8 
tyrosine, suggesting that catecholamine synthesis, re-
lease and receptor activation are necessary for meth-
amphetamine-induced depression of TH. Because GABA-
ergic neurons are thought to be involved in the stria-
12 
tonigral pathway ,agents which elevated GAB A levels 
were studied for possible effects on the methamphetamine 
model. Those results show that several GABA" transa-
minase inhibitors block the ability of methamphetamine 
to reduce the apparent Vmax of TH. From this we con-
clude that the GABAergic systems involved in the regu-
lation of nigral dopaminergic neurons can be made to 
antagonize the effects of amphetamine-like agents. 
Methods 
Male Sprague-Dawley rats (180 to 250" grams) were 
housed under l2-hour light-dark cycles, fed a standard 
diet 2~ libitu~l and allowed free access to WGter. Meth-
11 
amphetamine was dissolved in 0.9% NaCl to a concentra-
tion of 10 mg/ml. The animals received methamphetamine 
(10 mg/kg, s.c.) at 6 p.m., midnight, 6 a.m., 12 noon 
and 6 p.m. Thirty-six hours after the initial injec-
tion, rats were sacrificed by decapitation and brains 
were removed and placed on an ice-cold surface. The 
neostriata were removed, frozen on dry ice and assayed 
for TH activity within 3 days. TH activity was mea-
10 
sured by the method of Nagatsu et ale ,with satura-
ting concentrations of the pteridine cofactor, DMPH4-
Appropriate doses of a GABA transaminase (GABA-T) 
inhibitor, aminoosyacetic acid (AOAA) or y-acetylenic 
GABA (gAG), were administered intraperitoneally, con-
currently with methamphetamine. Ethanolamine-O-sulfate 
(BOS) , another GABA-T inhibitor, 400 ~g, was dissolved 
in 10 ~l of artificial cerebral spinal fluid, adjusted 
to pH 7.4 and injected stereotaxically under ether 
anesthesia in a single dose into the lateral ventricle, 
2-6 hours before starting the subacute methamphetamine 
regimen. Control rats for the EOS experiment received 
intraventricular 10 ~l injections of artificial CSF. 
In experiments requiring temperature regulation, 
rectal temperatures were monitored periodically and 
rats were warmed as needed to keep body temperature 
between 36° and 38° C. 
12 
yAG was donated by Merrell International Research 
Center, EOS was purchased from Aldrich Chemical Company 
and AOAA was acquired from Sigma Chemical Company. 
R~sults 
AOAA inhibited methamphetamine-induced depression 
of TH in a dose dependent manner (Fig. 1). The EDso 
was about 7 mg/kg and the maximal response was achieved 
at 20 mg/kg. Neither low nor high doses (5 and 40 mg/ 
kg) of AOAA, given alone every 6 hours for 5 total 
doses, affected the apparent Vmax of TH. 
Rectal temperatures, measured 24 hours after the 
first injection, indicated that methamphetamine pro-
duced hyperthermia, and AOAA (20 mg/kg) produced hypo-
thermia even with concurrent methamphetamine administra-
tion (Fig. 2). Another report showing that alterations 
in environmental temperature cause changes in adrenal 
15 
TH activity ,suggested that hypothermia alone caused 
by AO_~ might antagonize the effect of methamphetamine 
on neostriatal enzyme activity. Therefore, body tem-
perature was controlled to within 36° to 38° C during 
administration of methamphetamine and AOAA in separate 
experiments. There was no significant difference in TH 
activity between normothermic and hypothermic rats 
(Fig. 3) suggesting that hypothermia alone did not ac-




















































































































































































































































































































































































































































































FIG. 3 Effect of temperature control on methamphe-
tamine-induced neostriatal TH depression. Numbers in 
parenthesis refer to the number of animals per group. 
(*) p <0.01 compared to saline control. 
15 
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duced TH depression. 
A second GABA-T inhibitor, yAG, was also evaluated 
for its effect on methamphetamine-induced TH depression. 
Concurrent administration of 15 mg/kg of yAG signifi-
cantly antagonized and 40 mg/kg completely antagonized 
the TH depression; 1 and 5 mg/kg of yAG were ine£-
fective (F~g. 4). 
A single .intraventricu1ar administration of 400 ~g 
of EOS' completely reversed the effect of methampheta-
mine on TH, whereas EOS alone had no effect (Fig. 5). 
At maximal doses of each GABA-T inhibitor, general 
motor activity was obviously reduced and the rats ex-
hibited somewhat reduced stereotypic behavior. This 
sedation alone, however, did not appear to be responsi-
ble for the antagonism of the methamphetamine-induced 
TH depression because the concurrent administration of 
pentobarbital (25 mg/kg) had no effect on the TH de-
pression despite a greater level of sedation than 
that produced by maximal doses of any of the GABA-T 
inhibitors. 
A drug from another class, the benzodiazepines, 
3 
which are thought to facilitate GABA-actions , was 
evaluated to see whether it too could block the action 
of methamphetamine on neostriatal TH. Diazepam (0.3 
to 6.0 mg/kg), given concurrently with the methamphe-
FIG. 4 Neostriatal TH activity with increasing doses 
of gAG. Drugs were administered as described in the 
legend of Fig. 1. Numbers in parenthesis refer to the 
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FIG. 5 Neostriatal TH activity with EOS, given 
only once, combined with the methamphetamine sche-
dule described in the legend of Fig. 1. Numbers 
in parenthesis re r to the number of animals per 
group. (*) p <0.01 compared to control. 
20 






















tamine, did not block neostriatal TH depression 
Discussion 
17 i9 6 4 
The maximal doses of AOAA, ,gAG and EOS used 
in these experiments have been demonstrated to in-
crease GABA levels several-fold. Although AOAA and 
gAG can also inhibit glutamic acid decarboxylase (GAD) 
to an important degree, EOS is considerably more sel-
4 
ective, causing little GAD inhibition in vitro. This 
indicates that a functional increase in GABA levels is 
responsible for antagonizing the effect of the amphe-
tamine on TH. 
Since a range of diazepam doses failed to antago-
nize the action of methamphetamine on neostriatal TH, 
it appears that GABA-T inhibitors may be able to uni-
quely activate GABAergic systems to counteract the 
methamphetamine effect. It is possible, however, that 
9 
a well defined GABAmimetic such as muscimol could 
exert an antagonism similar to that seen with GABA-T 
inhibitors. 
OUT hypothesis was that methamphetamine decreases 
neostriatal TH activity primarily by decreasing the 
firing rate of the nigral dopamine cells and that the 
GABA-T inhibitors act by blocking the methamphetamine-
induced suppression of these cells. The research of 
other investigators supports the observations that 
22 
GABA-T inhibitors antagonize the effects of methamphe-
18 
tamine. Walters et al. have shown that AOAA and the 
GABA agonist, muscimol, can antagonize electrophysio-
logical effects of amphetamine. These workers evalu-
ated the effect of concurrent AOAA treatment on amphe-
tamine-induced suppression of the firing of neurons in 
the zona compacta of the substantia nigra and showed 
that AOAA (SO mg/kg, i.p.) will antagonize this effect 
of amphetamine at doses comparable to those used in 
this study. 
The primary site of action of the GABA-T inhibi-
tors in antagonizing the suppression of neostriatal TH 
could be in the striatum or in the nigra. A decrease 
of inhibitory input to the nigral dopaminergic cells 
could begin with striatal GABAergic interneurons sup-
13 
pressing the inhibitory striatonigral pathway how-
ever, it has been shown that this pathway need not be 
intact for methamphetamine to depress TH activity in 
5 
the neostriatum. It appears, then, that the GABA-T 
inhibitors may be acting primarily in the substantia 
11 
nigra, where GABAergic interneurons may reside 
23 
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PART THREE 
THE EFFECT OF STRIATONIGRAL PATHWAY LESIONS ON 
METHAMPHETA~1INE-INDUCED DEPRESSION OF 
TYROSINE HYDROXYLASE 
Introduction 
The abuse of amphetamine and related drugs fre-
qucntly results in personality changes that essentially 
mimic certain forms of psychotic behavior. High dose 
parenteral abuse, referred to as "speeding," often pro-
18 
duces a state similar to paranoid schizophrenia Bio-
chemical changes in the brain that occur during such an 
exposure to amphetamine may be linked to the under-
lying causes of non-drug related psychopatholog)r. Our 
goal has been to determine the mechanism for biochemi-
cal changes that are observed in an animal model of 
parenteral abuse, specifically changes in tyrosine hy-
droxylase (TH) activity seen in the nigro-striatal 
dopaminergic system. 
Several models have been used to demonstrate 
changes in the apparent Vmax of TH in the nigrostriatal 
system following amphetamine or methamphetamine intoxi-
12,7,11 12 
cation . The model developed by Koda and Gibb 
was used in the experiments reported here; this model 
consists of five parenteral (s.c.) doses of methamphe-
ta~ine over a 24 hour period, followed by measurement 
of neostriatal TH, 36 hours after the first dose. Meth-
amphetamine-induced TH depression in this model can be 
block0d by neuroleptics or GABA transaminase inhibi-
9 
tors . 
Studies on the regulation of TH in the adrenal 
medulla have shown that increased preganglionic nerve 
activity, presumably excitatory to chromaffin cells, 
20 
causes an increase in adrenal TH Electrophysiologi-
cal studies of the dopaminergic cells of the pars com-
pacta of the substantia nigra have demonstrated that 
amphetamine greatly decreases the firing rate of these 
neurons. Haloperidol alone only slightly increased 
the firing rate, but completely inhibited the amphe-
5 
tamine effect. These two pieces of information led 
2 
Buening and Gibb to propose that the continuous sup-
pression of dopamine cell firing by methamphetamine 
would lead to the converse of the situation in the 
adrenal medulla mentioned previously, i.e., decreased 
excitation of the nigral dopamine neurons would lead 
13 
to a decrease in the synthesis of TH. Kogan et ale 
then demonstrated that continuous inhibition of the 
29 
nigral DA cells caused by the continuous action of meth-
amphetamine resulted in decreased TH activity in cell 
bodies in the nigra. They then postulated that less 
TH was transported by axoplasmic flow to the neostriatum, 
and that this explained the consequent decrease in ty-
rosine hydroxylase in the neostriatum. 
Thus it has been proposed that the pr ry effect 
of methamphetamine is to turn on the striatonigral 
negative feedback pathway which leads to the decrease 
of neostriatal TH. This is consistent with the ob-
servation that the striatonigral pathway mediates the 
amphetamine-induced depression of nigral dopaminergic 
3 4 
cell firing' ; therefore, if this descending inhibi-
tory pathway were also the mediator of methampetamine-
induced TH depression, the elimination of this tract 
would block the TH depression on the lesioned side. 
This hypothesis was tested in the present report by 
a kainic acid lesion in the neostriatum, which should 
17 
destroy interneurons and efferent tracts , and also 
30 
by mechanical lesions of the striatonigral pathway just 
rostral to the substantia nigra. 
Materials 
3 
Tritiated tyrosine (L-3', 51, H-tyrosirie) was pur-
14 
chased from Amersham Searle and glutamic acid (L-l, 
C-glutamate) from New England Nuclear. All other chem-
icals were acquired from Sigma Chemical. y-Acetylenic 
GABA was generously supplied by Merrill International 
Research Center and the haloperidol was donated by 
McNeil Laboratories. Methamphetamine sulfate was ob-
tained from the National Institute of Drtig Abuse. 
31 
Methods 
Kainic acid lesions of the neostriatum were made 
on male Sprague-Dawley rats weigl1ing between 180 and 
210 g. The rats were anesthetized with ether, the dor-
sal cranium was exposed, the midline was estimated 
from the medial suture of each rat, and the inter-
aural line, as defined by the ear bars, was used as 
the anterior-posterior zero. Lesion locations were de-
14 
scribed according to the Konig and Klippel atlas 
Kainic acid was dissolved in artificial cerebral 
spinal fluid to a concentration of 3 mg/ml, degassed 
and the pH was adjusted to 7.4. Coordinates for the 
injection site were anterior 7.9 mm, lateral 2.6 mm 
and ventral 0.5 mm. A 3D-gauge cannula that had an 
electrolytically tapered, blunt point (Hamilton) was 
lowered into the caudate and O.5~1 of the kainic acid 
solution was injected over a 1 minute period; the can-
nula was withdrawn after another 2 minutes, the burr 
hole was filled with bone wax and the skin was sutured. 
Wire-knife lesions of the crus cerebri were made 
with a 25-gauge cannula, bent slightly at its end, 
which contained a 33-gauge wire that could be extended 
2.8 mm from the guide cannula at an angle of 45 0 to 
the vertical axis, the same angle of the crus ccrebri 
at the level of anterior 3.3 mm. Rats (240 to 280 g) 
32 
were anesthetized with Nembutal, placed in a stereo-
taxic holder and the cranium exposed. The cannula tip 
was lowered to a position just above the crus cerebri, 
anterior 3.3 mm, lateral 4.4 mm and ventral -0.4 mm. 
The wire was then extended and withdrawn every 100 ~m 
as the crannula was lowered another 2.2 mm, which ef-
fectively created a rectangular lesion encompassing 
all but the most medial 1.5 mm of the crus cerebri. 
Histological evaluation of the extent of the lesion 
was made for each rat. 
The electrothermic lesions of the crus cerebri 
were essentially the same as that reported by Gale et 
8 
al. ; spherical lesion of approximately 1 mm was made 
that was centered at anterior 3.3 mm, lateral 2.5 mm 
and ventral 215 mm. 
Five injections of methamphetamine (10 mg/kg, s.c.) 
were administered, once every 6 hours beginning at 
6 p.m. Rats were sacrificed 36 hours after the first 
injection, the brain was removed, placed on ice and 
sectioned with a coronal razor cut through the optic 
chiasm. Right and left neostriata were removed from 
the rostral block and frozen on dry ice. In crus cere-
bri lesioned rats the caudal block was placed in an 
aluminum foil cup (2.S cm X 3 cm deep), surrounded with 
OCT compound (Tissue c) and immersed in a pentane-
dry ice mixture for 15 seconds. These blocks were 
mounted in a microtome-cryostat and 10 micron sections 
were cut through the lesion area for histological ver-
ification. When GAD was to be measured in the nigra, 
sectioning was continued and 200 pm se ons were 
taken through the complete extent of t ~ nigra. These 
sections were lyophylized and the right and left sub-
stantia nigra reticulata samples were dissected, with 
the aid of a dissecting microscope, from the region of 
the emergence of the third cranial nerve. The ?ample 
size ranged from 10 to ZO ~g dry weight. 
Tyrosine hydroxylase was measured by the method 
15 
of Nagatsu et ale which is a tritium displacement 
assay. Tissues were homogenized in 30 volumes of O.Z% 
Triton X - 100, incubated in a solution containing so-
_3 
dium acetate (O.Z M), Fe++ (10 M), mercaptoethanol 
_4 (0.1 M) and tyrosine (10 M, 0.4 ~Ci); pH of the re-
action mixture was 6.0. 
Glutamate decarboxylase (GAD) was measured by a 
1 
modification of the procedure of Albers and Brady . 
33 
Lyophilized tissue was weighed, homogenized in 30 pI of 
0.1% bovine serum albumin, O.Z% Triton X-lOO and dith-
_ 3 
iothreotol (4 X 10 M) and centrifuged 10 min. at 
3000xg in the homogenizer. Ten ~l of the supernatant 
was used in the GAD ass \·,-hich was run in dupl icate. 
34 
The reaction mixture contained potassium phosphate buf-
14 
fer (38 mM), sodium glutamate (12 mM), l-L- C glutamic 
acid, (0.1 ~Ci), pyridoxal phosphate (0.2 mM) and KCl 
(1.0 roM); the pH of the final reaction mixture was 6.5. 
The C02 trapping tube was identical to the reaction 
tube (6 mm X 50 mm) and contained a piece of filter 
paper (8 X 15 mm) wetted with 50 ~l of hyamine hydrox-
ide (1 M in methanol). The reaction tube and trap were 
joined with a 5 cm piece of rubber tubing, secured to-
gether with a rubber band and incubated at 37° for 
60 min. The reaction was stopped by injection of 100 
~l of 5 N H2S04 through the rubber connecting tube, in-
to the reaction tube. The tubes were again incubated 
for 30 minutes at 37° C in a horizontal position to 
complete trapping; with the filter paper present, 
trapping was complete by 15 minutes. The filter paper 
was transferred to a 4 ml scintillation vial (Beck-
man Biovial) and the trapping tube was washed with 
4 ml of cocktail. To calculate the enzyme activity, 
the CO 2 trapping efficiency was assumed to be 100%. 
Student's t test was used to evaluate all com-
parisons except in the kainic acid lesion experiment, 
where the Sequential Studentized Range test was used. 
Results 
Following the injection of kainic acid into the 
35 
neostriatum, rats exhibited barrel-rolling seizure 
activity shortly after regaining consciousness and were 
anorexic and adipsic for about 2 days after making the 
lesion. However, by 12 days mortality was only 20% 
and most of the rats had gained 10 to 20 grams in body 
weight. 
After the l2-day recovery period, the methamphe-
tamine regimen was begun. Preliminary studies demon-
strated that neostriatal TH activity in eSF-injected 
control rats was not different from that in rats with 
uninjected striata whether rats were treated with meth-
amphetamine or saline; therefore, the uninjected con-
tralateral side was used as a control throughout the 
kainic acid lesion study. Figure 1 shows that meth-
amphetamine causes a 50% depression in TH on the un-
lesioned side; however, the kainate lesion did not 
prevent the tyrosine hydroxylase (TH) depression in 
methamphetamine-treated rats; in this case TH was de-
creased to only 34% of control. Thus the lesion it-
self, which should have eliminated the striatonigral 
pathway, did not diminish the TH depression caused by 
methamphetamine. 
GABA transaminase inhibitors such as yAG have 
been shown to block the methamphetamine-induced de-
9 
pression of neostriatal tyrosine hydroxylase. This 
FIG. 1 Neostriatal TH activity in kainic acid le-
sioned striata and contralateral, unlesioned striata. 
Twelve days after the lesion methamphetamine (10 mg/kg, 
s.c.) was given every 6 hours for 5 doses; yAG and 
haloperidol were given i.p. on the same schedule. TH 
activity was measured 36 hours after the first injec-
tion. Statistical comparisons were made only between 
treatments from the same side, i.e., kainic acid-les-
ioned methamphetamine treated versus kainic acid-
lesioned saline treated. 
(*) p <0.05 compared to saline control 


















































































































































































protective ability of yAG appears to have been dimin-
ished by the kainic acid lesion because the TH depres-
sion of the lesioned side was not significantly antag-
onized by yAG at IS mg/kg, whereas this same dose sig-
38 
nificantly antagonized the depression of TH in the con-
tralateral unlesioned side when compared to contra-
lateral unlesioned striatum of rats receiving only 
methamphetamine. Thus, the lesion appears to have de-
creased the ability of the GABAergic systems that in-
teract with the dopamine cells to respond to the ef-
fects of a GABA-T inhibitor. The dose of yAG used in 
these experiments has been shown to be about an ED90 
for antagonism of the methamphetamine effect on neo-
9 
striatal TH , therefore, it is possible that a higher 
dose of yAG could exert some antagonism to this action 
of methamphetamine. 
Haloperidol has also been shown to protect against 
2 
the methamphetamine-induced TH depression. The dose 
of haloperidol used here significantly blocks TH de-
pression in both lesioned and non-lesioned neostriata. 
Thus, this effect of haloperidol is not altered by the 
kainic acid lesion, at least at the dosage level chosen 
for this experiment. 
The kainic acid lesion produces an asymmetrical 
motor behavior which is presumed to be related to un 
equal dopaminergic cell activity between the lesioned 
6 
and unlesioned nigrostriatal system. Rotational be-
havior was evaluated in each treatment group by ob-
serving the direction of rotation and relative inten-
39 
sity of the turning during the 10-20 minute period fol-
lowing the first injection of methamphetamine. Ten 
minutes after injection, rats that were given metham-
phetamine (10 mg/kg s.c.) displayed ipsilateral ro-
tation at 6 to 9 turns per minutes; saline treated 
rats showed little spontaneous rotation. Anim~ls re-
ceiving yAG and methamphetamine turned ipsilaterally 
at a slower rate than those receiving methamphetamine 
alone. Haloperidol alone (not shown in Fig. 1) 
caused no rotation but when given in conjunction with 
methamphetamine caused a contralateral rotation, at a 
rate comparable to the group treated with yAG and 
methamphetamine. 
Wire-knife lesions also failed to block de-
pression of TH produced by methamphetamine (Fig. 2). 
GAD activity in the ipsilateral nigra decreased 36% 
indicating that there was significant destruction of 
the striatonigral pathway. Other investigators have 
reported that all GABAergic projections from the stri-
atal-pallidal complex may account for 70 - 80% of ni-
19 10 
gral GAD Our lesions left from 100 to 200 microns 
FIG. 2 Neostriatal TH activity (dotted bars) and 
nigral GAD activity (crosshatched bars) in rats with 
wire knife lesions of the crus cerebri on the right 
side. Eleven days after the lesion methamphetamine 
was given as described in the legend of Fig. 1. 
(*) P <0.01 compared to ipsilateral control 
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of the most medial aspect of the crus cerebri intact 
with the intention to avoid damaging the median fore-
brain bundle (MFB). Because the MFB contains the nigro-
striatal tract, it was thought that any damage to the 
MFB might interfere with the interpretation of the 
methamphetamine-induced changes in neostriatal TH. 
The GAD level in the control nigra was not 
changed by methamphetamine treatment (Fig. 2). When 
GAD was measured in the neostriatum over a 20-day per-
iod it was found to be unchanged, although TH activity 
was significantly depressed throughout the entire ob 
servation period (unpublished observation). 
The electrothermic lesion also failed to antago-
nize TH depression in the lesioned side (Fig. 3); this 
is the same result seen with the wire-kni lesion, 
which is expected since both lesions should create 
similar damage to the striatonigral tract. 
Discussion 
The original hypothesis set forth to explain the 
methamphetamine-induced depression of neostriatal TH 
can be considered in two aspects. First, chronic ex-
posure to methamphetamine causes a decrease in the fir-
ing rate of the nigral dopaminergic cells via the stri-
atonigral negative feedback pathway. Secondly, this 
decrease in dopaminergic cell activity reduces the rate 
FIG. 3 Neostriata1 TH activity in electrothermic 
lesioned rats. Thirteen days after the lesion in the 
right crus cerebri, methamphetamine was given as de-
scribed in the legend of Fig. 1. (*) P <0.05 com-
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of synthesis of TH; consequently, less TH is trans-
ported to the neostriatum by axoplasmic flow result-
ing in a decrease in neostriatal TH. 
The first aspect of this hypothesis was not su-
ported by the experiments reported here. According to 
this hypothesis all three types of lesions should have 
attenuated or eliminated feedback inhibition from the 
neostriatum to the substantia nigra; however, none of 
the lesions blocked the methamphetamine-induced depres-
sion in TH. This result was consistently obtained in 
duplications of these experiments. We conclude from 
these observations that a different mechanism than the 
postulated striatonigral negative edback must account 
for the decrease of striatal TH activity. Although the 
striatonigral pathway certainly must inhibit these 
dopaminergic cells at lower doses of methamphetamine, 
another negative feedback system must be operating at 
this high dose of methamphetamine. It should be noted 
that the threshold dose of methamphetamine for TH de-
12 
pression is 6 to 8 mg/kg , whereas a considerably 
lower dose, 1.6 mg/kg, was used by Bunney and Aghajan-
3 
ian to demonstrate the action of the striatonigral 
tract in the amphetamine silencing of dopamine neurons. 
It, therefore, appears that alternative neuronal 
systems e st which can produce feedback inhibition of 
dopamine neurons in the absence of the striatonigral 
pathway and which are probably normally active with 
high doses of methamphetamine. One possible alterna-
tive might be that local circuits in the striatum com-
posed of interneurons exert a presyaptic inhibition 
on dopaminergic boutons; however, the kainic acid 
46 
lesion study eliminates this possibility. Other alter-
natives remain to explain the source of inhibition of 
TH activity, such as dopaminergic autoreceptors in the 
nigra and the striatum, local interneuronal circuits 
in the nigra or afferent nigra I inhibition from other 
sources such as the raphe. Another possibility re-
mains which may be unrelated to classical neuronal in-
hibition; it is possible that there is direct damage 
of the nigrostriatal dopaminergic terminals by a toxic 
action of methamphetamine. 
Other investigators have evaluated the regulation 
of dopamine metabolism in the kainate-lesioned striata. 
One study indicated that haloperidol-induced activation 
of TH, seen as a decrease in Km for the pteridine co-
21 
factor, does require an intact striatum ; this shows 
that striatal interneurons and/or the striatonigral 
pathway are essential for neuroleptic-induced activa-
tion of TH. But another report showed that dopamjne 
turnover is still increased by llaloperidol in the kai-
47 
22 
nic acid lesioned striatum Thus it appears that 
pathways involved in methamphetamine-induced depression 
of neostriatal TH activity are not the same as those 
required for haloperidol to activate TH. However, both 
the ability of haloperidol to increase dopamine turn-
over, and the ability of haloperidol to block methamphe-
tamine changes in neostriatal TH activity (Fig. 1) seem 
to work independently of the neurons destroyed with the 
kainic acid lesion, perhaps through the same pathway. 
In contrast to the lack of effect of the kainic acid 
lesion on the protective ability of haloperidol, the 
protective ability of the GABA-T inhibitor, yAG, ap-
pears to have been compromised by the lesion (Fig. 1); 
therefore, the striatonigral pathway and/or striatal 
interneurons must play a role in the ability of yAG to 
antagonize the methamphetamine-induced depression of 
TH. 
Since nigral GAD activity was unchanged with meth-
amphetamine treatment, methamphetamine may be acting 
specifically on nigral dopamine cells instead of caus-
ing a general depression of many enzymes. Following 
the subacute methamphetamine regime, neither GAD nor 
choline acetyl transferase in the neostriatum are 
changed significantly during a 20-day period; through-
out this time neostriatal TH is significantly depressed 
48 
(unpublished observations). This observation also ar-
gues against a generalized depression of enzyme levels 
caused by a nonspecific toxic action of methamphetamine. 
Thus it appears that if there is destruction of neo-
striatal boutons, the dopaminergic nigrostriatal fibers 
may be specifically affected. 
The apparent decrease in responsiveness of the 
nigrostriatal system to the effects of yAG in the pre-
sence of methamphetamine indicates that the GABAergic 
projection to the nigral dopamine cells plays a role 
in suppressing neostriatal TH changes; the construction 
of a complete dose response curve would elucidate 
whether there is a change in potency and/or a change 
in efficacy. If haloperidol was to act predominately 
at presynaptic sites at this high dose of 3 mg/kg, one 
would expect that little difference in responsiveness 
would be brought about by the kainic acid lesion, as 
is suggested by the results in Fig. 1. 
There were interesting differences in rotational 
behavior seen with the combinations of methamphetamine 
with yAG or haloperidol. The combination of methamphe-
tamine and yAG resulted in ipsilateral rotation while 
haloperidol used in combination with ~ethamphetamine 
caused a contralateral rotation. Since only haloperi-
dol of Ted signific3nt protection to neostriatal TH 
49 
on the lesioned side, the ability to reverse rotational 
behavior elicited by methamphetamine in kainic acid 
lesioned neostriata may correlate with the ability to 
antagonize neostriatal TH depression. If this is so, 
one might be able to use higher doses of yAG, for ex-
ample, which could produce some protection against neo-
striatal TH depression on the lesioned side and at the 
same time reverse the rotational behavior caused by 
methamphetamine. 
The decrease in nigral GAD seen in the wire knife 
experiment is less than that reported by others. The 
19 
study of Spano et al. ,who showed a 70% decrease in 
GAD following an electrothermic lesion, differed from 
our experimental design in two significant respects. 
First, the lesion apparently included the lateral mar-
gin of the MFB whereas it was our intention to avoid 
this fiber bundle. Secondly, in their study only 4 
days elapsed between the lesion and measurement of the 
8 
enzyme while we waited 13 days. Gale et al. found 
that GABA levels were depressed as much as 70% 7 days 
after crus cerebri lesion but another group reported 
that nigral GABA levels were decreased only 55% 12 days 
16 
after wire knife lesions of the crus cerebri. This 
indicates that the time of GAD measurement after the 
lesion of the crus cerebri may be important and tl1at 
GAD may increase with time. 
The second aspect of this hypothesis, i.e., de-
creased synthesis and transport leading to decreased 




1. Albers, R.W. and Brady, R.O., The distribution of 
glutamic decarboxylase in the nervous system of 
the rhesus monkey, J. Biol. Chem., 234 (1959) 
926-928. 
2. Buening, M.K. and Gibb, J.W., The effect of re-
peated large doses of methamphetamine on adrenal 
and brain tyrosine hydroxylase, European J. 'Phar-
macol., 26 (1974) 30-34. 
3. Bunney, B.S. and Aghajanian, G.K., d-Amphetamine-
induced inhibition of central dopaminergic neurons: 
mediation by a striato-nigral feedback pathway, 
Science, 192 (1976) 391-393. 
4. Bunney, B.S. and Aghajanian, G.D., d-Amphetamine-
induced depression of central dopamine neurons: 
evidence for mediation by both autoreceptors and 
a striato-nigral feedback pathway, N.S. Arch. 
Pharmacol., 304 (1978) 255-261. 
5. Bunney, B.S. and Aghajanian, G.K. and Roth, R.H., 
Amphetamine, L-dopa and apomorphine: Effects on 
activity of rat dopaminergic neurons, Federation 
Proc., 32 (1973) 247. 
6. Coyle, J.T., Schwartz, R., Lesion of striatal 
neurons provides a model for Huntington's chorea, 
Nature (London), 263 (1976) 244-246. 
7. Fibiger, H.D. and McGeer, E.G., Effect of acute 
and chronic methamphetamine on tyrosine hydroxy-
lase activity in brain and adrenal medulla, Euro-
pean J. Phamracol., 16 (1971) 176-180. 
8. Gale, K., Guidotti, A. and Costa, E., Dopamine-
sensitive adenylate cyclase: localization in the 
substantia nigra, Science, 195 (1977) 503-505. 
9. Gibb, J.W. and Hotchkiss, A.J., Role of striato-
nigral pathway and GABA systems in methamphetamine-
induced depression of striatal tyrosine hydroxylase, 
In E. Usdin d.), Cate lamlnes: Basic and Clini-
cal Frontiers, Fourth International Catecholamin 
Symposium, Pergamon, New York (in press). 
10. Hattori, T., McGeer, P.L., Fibiger, H.D. and Mc-
Geer, E.G., On the source of GABA-containing ter-
minals in the substantia nigra. Electron micro-
scopic auto radiographic and biochemical studies, 
Brain Research, 54 (1973) 103-114. 
52 
11. Huberman, H., Eison, M.S., Bryan, K.S. and Ellison, 
G., A slow-release silicone pellet for chronic 
amphetamine administration, European J. Pharmacol., 
45 (1977) 237-242. 
12. Koda, L.Y. and Gibb, J.W., The effect of repeated 
large doses of methamphetamine on adrenal arid 
brain tyrosine hydroxylase, Pharmacologist, 13 
(1971) 253. 
13. Kogan, F.J., Nichols, W.K. and Gibb, J.W., In-
fluence of methamphetamine on nigral and striatal 
tyrosine hydroxylase activity and on striatal dop-
amine levels, European J. Phamracol., 36 (1976) 
363-371. 
14. Konig, J.F.R. and Klippel R.A., The rat brain, 
a stereotaxic atlas, Williams and Wilkins, 
Baltimore, 1963. 
15. Nagatsu, T., Levitt, M., and Udenfriend, S., A 
rapid and simple radioassay for tyrosine hydroxy-
lase activity, Anal. Biochem., 9 (1964) 122-126. 
16. Racagni, G., Bruno, G., Cattabeni, F., Maggi, A., 
DiGuilio, A.M., Parenti, M. and Gropetti, A., 
Functional interrelation between rat substantia 
nigra and striatum: GABA and dopamine interrela-
tion, Brain Research, 134 (1977) 353-358. 
17. Schwartz R. and Coyle, J.T., Striatal lesions with 
kainic acid: Neurochemical characteristics, Brain 
Research, 127 (1977) 235-249. 
18. Snyder, S.H., Catecholamines in the brain as medi-
ators of amphetamine psychosis, Arch. Gen. Psychiat., 
27 (1972) 169-179. 
19. Spano, P.F., Trabucchi, M. and DiChiara, G., Lo-
calization of nigral dopamine-sensitive adenylate 
cyclase on neurons originating from the corpus 
striatum, Science, 196 (1977) 134.3-1345. 
20. Thoenen, H., Mueller, R.H. and Axelrod, J., In-
creased tyrosine hydroxylase activity after drug-
induced alteration of sympathetic transmission, 
Nature (London), 221 (1969) 1264. 
21. Tissari, H.A., Porceddu, M.L., Argiolas, A., 
Dichiara, G. and Gessa, G.L., Dopamine-synthesis 
and tyrosine-hydroxylase are regulated by inde-
pendent DA-receptor mediated mechanism, Life 
Sciences, 23 (1978) 653-658. 
22. Wuerthele, S.M. and Moore, K.E., Neuroleptics and 
nigrostriatal dopaminergic neurons, Neuroscience 
Abstr., 4 (1978) 154. 
53 
